DABIGATRAN ETEXILATE 110 MG CP

Dabigatran Etexilate
$0.9221per EA

Strength

110 mg/1

NDC

31722066660

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207961

On Market Since

8/13/2024

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

-9.5%

3M

-27.4%

6M

-46.4%

1Y

-53.2%

3Y

N/A

5Y

N/A

All

-47.8%